Enzymatica AB vs Johnson & Johnson
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Johnson & Johnson is the larger company by market value: $652.5 B against $63 M for Enzymatica AB, 10357 times as much (market caps of Jan 5, 2024 for Enzymatica AB and Oct 29, 2026 for Johnson & Johnson). Enzymatica AB's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Revenue by fiscal year
US$ billions, as reported in each year's annual results.
Side by side
| Measure | Enzymatica AB ENZY.ST | Johnson & Johnson JNJ · #23 in the world |
|---|---|---|
| Profile | ||
| Country | 🇸🇪 Sweden | 🇺🇸 USA |
| Sector | Healthcare | Healthcare |
| Industry | Pharmaceutical | Pharmaceutical |
| Founded | — | 1886 |
| Size | ||
| Market cap | $63 M* | $652.5 B |
| Revenue | — | $94.2 B |
| Net income | — | $26.8 B |
| Employees | — | 138,200 |
| Valuation | ||
| P/E ratio | — | 40.5× |
| Price to sales | — | 6.6× |
| Price to book | — | 8.0× |
| Free cash flow yield | — | 3.0% |
| Altman Z-score zone | — | — |
| Data as of | Market cap Jan 2024 | Market cap Oct 2026 |
▲ marks the better of the two where higher or lower is better; size and valuation multiples are marked for neither
Questions and answers#
Which is bigger, Enzymatica AB or Johnson & Johnson?
Johnson & Johnson is the larger company by market value: $652.5 B against $63 M for Enzymatica AB, 10357 times as much (market caps of Jan 5, 2024 for Enzymatica AB and Oct 29, 2026 for Johnson & Johnson). Enzymatica AB's value is the last on file, from Jan 5, 2024: no market-data feed is connected for its exchange yet.
More about Enzymatica AB
More about Johnson & Johnson
Sources#
Every figure on this page comes from these, with the date shown next to it.